Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Merck Gross Margin 2010-2024 | MKKGY

Current and historical gross margin for Merck (MKKGY) over the last 10 years. The current gross profit margin for Merck as of June 30, 2024 is %.
  
Merck Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-06-30 $22.58B $13.15B 58.23%
2024-03-31 $22.60B $13.12B 58.04%
2023-12-31 $22.72B $13.41B 59.03%
2023-09-30 $22.91B $13.76B 60.06%
2023-06-30 $23.13B $14.17B 61.26%
2023-03-31 $23.27B $14.40B 61.88%
2022-12-31 $23.42B $14.44B 61.64%
2022-09-30 $23.58B $14.70B 62.33%
2022-06-30 $23.60B $14.69B 62.24%
2022-03-31 $23.54B $14.69B 62.39%
2021-12-31 $23.29B $14.59B 62.66%
2021-09-30 $22.79B $14.20B 62.32%
2021-06-30 $22.12B $13.65B 61.71%
2021-03-31 $20.79B $12.73B 61.24%
2020-12-31 $20.03B $12.22B 61.02%
2020-09-30 $19.42B $11.87B 61.12%
2020-06-30 $18.73B $11.61B 62.00%
2020-03-31 $18.66B $11.68B 62.59%
2019-12-31 $18.09B $11.36B 62.82%
2019-09-30 $17.42B $10.98B 63.01%
2019-06-30 $17.27B $10.91B 63.15%
2019-03-31 $17.24B $10.93B 63.43%
2018-12-31 $17.52B $11.17B 63.72%
2018-09-30 $17.87B $11.47B 64.18%
2018-06-30 $17.90B $11.53B 64.43%
2018-03-31 $17.75B $11.49B 64.76%
2017-12-31 $17.32B $11.31B 65.30%
2017-09-30 $16.90B $11.10B 65.67%
2017-06-30 $16.68B $11.01B 65.99%
2017-03-31 $16.70B $11.00B 65.90%
2016-12-31 $16.63B $10.87B 65.38%
2016-09-30 $16.29B $10.71B 65.74%
2016-06-30 $15.63B $10.40B 66.53%
2016-03-31 $14.89B $10.02B 67.30%
2015-12-31 $14.31B $9.78B 68.38%
2015-09-30 $13.91B $9.36B 67.29%
2015-06-30 $14.32B $9.56B 66.73%
2015-03-31 $14.59B $9.81B 67.25%
2014-12-31 $14.78B $10.09B 68.26%
2014-09-30 $15.11B $10.64B 70.46%
2014-06-30 $14.86B $10.69B 71.98%
2014-03-31 $14.80B $10.77B 72.79%
2013-12-31 $14.72B $10.75B 73.02%
2013-09-30 $14.64B $11.73B 80.08%
2013-06-30 $14.55B $11.61B 79.77%
2013-03-31 $14.30B $11.32B 79.17%
2012-12-31 $14.00B $11.97B 85.54%
2012-09-30 $13.66B $11.64B 85.19%
2012-06-30 $13.69B $12.65B 92.42%
2012-03-31 $13.85B $12.75B 92.10%
2011-12-31 $14.08B $12.98B 92.23%
2011-09-30 $14.47B $13.38B 92.44%
2011-06-30 $14.03B $12.14B 86.50%
2011-03-31 $13.05B $12.25B 93.87%
2010-12-31 $12.34B $11.54B 93.52%
2010-09-30 $11.61B $10.81B 93.11%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $19.519B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.933B 30.76
Takeda Pharmaceutical (TAK) Japan $43.146B 8.98
Astellas Pharma (ALPMY) Japan $18.712B 17.23
Sandoz Group AG (SDZNY) Switzerland $18.274B 0.00
United Therapeutics (UTHR) United States $16.168B 15.90
Summit Therapeutics (SMMT) United States $13.842B 0.00
Neurocrine Biosciences (NBIX) United States $12.982B 34.38
Shionogi (SGIOY) Japan $12.199B 12.22
Catalent (CTLT) United States $11.479B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.686B 0.00
Orion OYJ (ORINY) Finland $6.458B 18.16
Corcept Therapeutics (CORT) United States $6.295B 47.68
Ionis Pharmaceuticals (IONS) United States $5.999B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.578B 0.00
PTC Therapeutics (PTCT) United States $3.831B 0.00
Dyne Therapeutics (DYN) United States $2.796B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.620B 11.88
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.510B 15.00
NewAmsterdam Pharma (NAMS) Netherlands $2.362B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.265B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.170B 0.00
Soleno Therapeutics (SLNO) United States $2.034B 0.00
Xencor (XNCR) United States $1.768B 0.00
Evotec AG (EVO) Germany $1.666B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.628B 0.00
Indivior (INDV) United States $1.606B 6.54
Guardian Pharmacy Services (GRDN) United States $1.511B 0.00
Ocular Therapeutix (OCUL) United States $1.503B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.448B 0.00
Harrow (HROW) United States $1.344B 0.00
Ardelyx (ARDX) United States $1.260B 0.00
ARS Pharmaceuticals (SPRY) United States $1.192B 0.00
Enliven Therapeutics (ELVN) United States $1.177B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.994B 0.00
Collegium Pharmaceutical (COLL) United States $0.981B 5.36
Bioventus (BVS) United States $0.940B 29.69
Relay Therapeutics (RLAY) United States $0.834B 0.00
Oruka Therapeutics (ORKA) United States $0.829B 0.00
Cronos Group (CRON) Canada $0.745B 0.00
USANA Health Sciences (USNA) United States $0.719B 13.34
Tourmaline Bio (TRML) United States $0.625B 0.00
Altimmune (ALT) United States $0.622B 0.00
Elite Pharmaceuticals (ELTP) United States $0.620B 0.00
Savara (SVRA) United States $0.599B 0.00
ProKidney (PROK) United States $0.598B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.591B 0.00
OmniAb (OABI) United States $0.572B 0.00
Verve Therapeutics (VERV) United States $0.533B 0.00
Esperion Therapeutics (ESPR) United States $0.530B 0.00
Xeris Biopharma Holdings (XERS) United States $0.523B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.494B 0.00
Organogenesis (ORGO) United States $0.485B 0.00
Zevra Therapeutics (ZVRA) United States $0.472B 0.00
Korro Bio (KRRO) United States $0.456B 0.00
Siga Technologies (SIGA) United States $0.451B 5.27
KalVista Pharmaceuticals (KALV) United States $0.449B 0.00
Akebia Therapeutics (AKBA) United States $0.419B 0.00
Larimar Therapeutics (LRMR) United States $0.415B 0.00
Aquestive Therapeutics (AQST) United States $0.348B 0.00
Avita Medical (RCEL) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.344B 139.50
Aldeyra Therapeutics (ALDX) United States $0.320B 0.00
4D Molecular Therapeutics (FDMT) United States $0.319B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.300B 0.00
Nature's Sunshine Products (NATR) United States $0.295B 17.54
Heron Therapeutics (HRTX) United States $0.257B 0.00
Aclaris Therapeutics (ACRS) United States $0.253B 0.00
Lexeo Therapeutics (LXEO) United States $0.252B 0.00
Lyell Immunopharma (LYEL) United States $0.248B 0.00
Acrivon Therapeutics (ACRV) United States $0.232B 0.00
Profound Medical (PROF) Canada $0.227B 0.00
Inhibikase Therapeutics (IKT) United States $0.215B 0.00
Silence Therapeutics (SLN) United Kingdom $0.193B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.193B 0.00
Nektar Therapeutics (NKTR) United States $0.188B 0.00
MediWound (MDWD) Israel $0.185B 0.00
Nanobiotix S.A (NBTX) France $0.160B 0.00
Telomir Pharmaceuticals (TELO) United States $0.151B 0.00
CytoDyn (CYDY) United States $0.150B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.148B 0.00
Metagenomi (MGX) United States $0.148B 0.00
Achieve Life Sciences (ACHV) Canada $0.146B 0.00
VAXART, INC (VXRT) United States $0.139B 0.00
Cassava Sciences (SAVA) United States $0.137B 0.00
Inotiv (NOTV) United States $0.130B 0.00
Protara Therapeutics (TARA) United States $0.129B 0.00
Galectin Therapeutics (GALT) United States $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.117B 0.00
Century Therapeutics (IPSC) United States $0.115B 0.00
Context Therapeutics (CNTX) United States $0.113B 0.00
Regulus Therapeutics (RGLS) United States $0.111B 0.00
Fractyl Health (GUTS) United States $0.110B 0.00
Innate Pharma SA (IPHYF) France $0.108B 0.00
Journey Medical (DERM) United States $0.108B 0.00
Avalo Therapeutics (AVTX) United States $0.098B 0.00
Pyxis Oncology (PYXS) United States $0.096B 0.00
ElectroCore (ECOR) United States $0.095B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.094B 0.00
Karyopharm Therapeutics (KPTI) United States $0.092B 0.00
Assertio Holdings (ASRT) United States $0.092B 24.00
Arch Biopartners (ACHFF) Canada $0.084B 0.00
Unicycive Therapeutics (UNCY) United States $0.083B 0.00
PMV Pharmaceuticals (PMVP) United States $0.081B 0.00
Champions Oncology (CSBR) United States $0.079B 0.00
Vivani Medical (VANI) United States $0.076B 0.00
OptiNose (OPTN) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.075B 0.00
Swiftmerge Acquisition (IVCP) United States $0.072B 0.00
Scienture Holdings (SCNX) United States $0.069B 0.00
Mural Oncology (MURA) Ireland $0.062B 0.00
AlloVir (ALVR) United States $0.058B 0.00
Iterum Therapeutics (ITRM) Ireland $0.054B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
CASI Pharmaceuticals (CASI) China $0.048B 0.00
BioVie (BIVI) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
SCYNEXIS (SCYX) United States $0.045B 0.00
Nutriband (NTRB) United States $0.044B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.040B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Tempest Therapeutics (TPST) United States $0.037B 0.00
FibroGen (FGEN) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.034B 0.00
Incannex Healthcare (IXHL) Australia $0.031B 0.00
Surrozen (SRZN) United States $0.030B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.024B 0.00
Carisma Therapeutics (CARM) United States $0.023B 0.00
Mannatech (MTEX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.022B 0.00
Vivos Therapeutics (VVOS) United States $0.022B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Jaguar Animal Health (JAGX) United States $0.015B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
NRx Pharmaceuticals (NRXP) United States $0.014B 0.00
PolyPid (PYPD) Israel $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Relmada Therapeutics (RLMD) United States $0.013B 0.00
Talphera (TLPH) United States $0.012B 0.00
CERo Therapeutics Holdings (CERO) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Conduit Pharmaceuticals (CDT) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.008B 0.00
Viracta Therapeutics (VIRX) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
Biomerica (BMRA) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.10
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Molecular Templates (MTEM) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.35
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 42.67